HC Wainwright raised their FY2028 earnings per share (EPS) estimates for Denali Therapeutics in a report issued on Tuesday, January 7th. HC Wainwright analyst A. Fein now expects that the company will ...
Stoke Therapeutics (NASDAQ:STOK – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC ...
Microvast Holdings jumped over 30% in premarket after it announced a breakthrough in its True All-Solid-State Battery ...
HC Wainwright has initiated coverage of Emergent BioSolutions (NYSE:EBS) at buy, citing sales of the company's ...
Hosted on MSN10d
HC Wainwright & Co. Initiates Coverage of NewAmsterdam Pharma Company N.V. (NAMS) with Buy RecommendationFintel reports that on December 30, 2024, HC Wainwright & Co. initiated coverage of NewAmsterdam Pharma Company N.V.
Avadel Pharmaceuticals missed the fourth quarter sales estimate by 5.12%. Still, the sales of its narcolepsy drug, LUMRYZ ...
Fintel reports that on January 2, 2025, HC Wainwright & Co. initiated coverage of Corvus Pharmaceuticals (NasdaqGM:CRVS) with a Buy recommendation. As of December 23, 2024, the average one-year ...
Analysts at a Wall Street investment bank have put the odds of incoming U.S. president Donald Trump creating a bitcoin ...
Fintel reports that on December 30, 2024, HC Wainwright & Co. initiated coverage of NewAmsterdam Pharma Company N.V. (NasdaqGM:NAMS) with a Buy recommendation. As of December 23, 2024, the average ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback